A biotechnology company designing immunotherapies for solid tumor cancers with a patient's white blood cells is raising $80 million in its initial public offering or IPO.
https://sciencebusiness.technewslit.com/?p=45015
#News #Press #Science #Business #Biotechnology #Cancer #SolidTumor #Finance #Immunotherapy TCells #ClinicalTrial #Lymphocytes #Investment #IPO #ImmuneSystem #Licensing #VentureCapital
#News #press #science #business #biotechnology #cancer #solidtumor #finance #Immunotherapy #ClinicalTrial #lymphocytes #investment #IPO #immunesystem #licensing #venturecapital
Precision T-Cell Solid Tumor Therapy Trial Underway
A clinical trial has begun testing a treatment for solid #tumor #cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells.
https://sciencebusiness.technewslit.com/?p=44842
#News #Science #Business #ClinicalTrial #Biotechnology #Tcells #Immunotherapy #SolidTumor #PrecisionMedicine #CompanionDiagnostic
#tumor #cancers #News #science #business #ClinicalTrial #biotechnology #Tcells #Immunotherapy #solidtumor #precisionmedicine #companiondiagnostic